These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 19901169
1. Optical coherence tomography in clinically isolated syndrome: no evidence of subclinical retinal axonal loss. Outteryck O, Zephir H, Defoort S, Bouyon M, Debruyne P, Bouacha I, Ferriby D, Lacour A, Labalette P, de Seze J, Vermersch P. Arch Neurol; 2009 Nov; 66(11):1373-7. PubMed ID: 19901169 [Abstract] [Full Text] [Related]
2. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis. Zaveri MS, Conger A, Salter A, Frohman TC, Galetta SL, Markowitz CE, Jacobs DA, Cutter GR, Ying GS, Maguire MG, Calabresi PA, Balcer LJ, Frohman EM. Arch Neurol; 2008 Jul; 65(7):924-8. PubMed ID: 18625859 [Abstract] [Full Text] [Related]
5. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis. Pueyo V, Martin J, Fernandez J, Almarcegui C, Ara J, Egea C, Pablo L, Honrubia F. Mult Scler; 2008 Jun; 14(5):609-14. PubMed ID: 18424482 [Abstract] [Full Text] [Related]
6. Quantifying axonal loss after optic neuritis with optical coherence tomography. Costello F, Coupland S, Hodge W, Lorello GR, Koroluk J, Pan YI, Freedman MS, Zackon DH, Kardon RH. Ann Neurol; 2006 Jun; 59(6):963-9. PubMed ID: 16718705 [Abstract] [Full Text] [Related]
7. Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography. Costello F, Hodge W, Pan YI, Eggenberger E, Coupland S, Kardon RH. Mult Scler; 2008 Aug; 14(7):893-905. PubMed ID: 18573837 [Abstract] [Full Text] [Related]
10. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Saidha S, Syc SB, Durbin MK, Eckstein C, Oakley JD, Meyer SA, Conger A, Frohman TC, Newsome S, Ratchford JN, Frohman EM, Calabresi PA. Mult Scler; 2011 Dec; 17(12):1449-63. PubMed ID: 21865411 [Abstract] [Full Text] [Related]
11. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, García-Layana A, Bejarano B, Villoslada P. Neurology; 2007 May 01; 68(18):1488-94. PubMed ID: 17470751 [Abstract] [Full Text] [Related]
12. Optical coherence tomography in neuromyelitis optica. de Seze J, Blanc F, Jeanjean L, Zéphir H, Labauge P, Bouyon M, Ballonzoli L, Castelnovo G, Fleury M, Defoort S, Vermersch P, Speeg C. Arch Neurol; 2008 Jul 01; 65(7):920-3. PubMed ID: 18625858 [Abstract] [Full Text] [Related]
17. Axonal loss in non-optic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential. Klistorner A, Garrick R, Barnett MH, Graham SL, Arvind H, Sriram P, Yiannikas C. Neurology; 2013 Jan 15; 80(3):242-5. PubMed ID: 23269599 [Abstract] [Full Text] [Related]
19. Is optical coherence tomography really a new biomarker candidate in multiple sclerosis?--A structural and functional evaluation. Gundogan FC, Demirkaya S, Sobaci G. Invest Ophthalmol Vis Sci; 2007 Dec 15; 48(12):5773-81. PubMed ID: 18055831 [Abstract] [Full Text] [Related]